A study to verify the symptoms of homoeopathic medicine Naphthalinum in cases of Allergic Rhinitis

Phase 3

Completed

• Conditions: Allergic rhinitis, unspecified,

• Registration Number: CTRI/2022/06/043022
• Lead Sponsor: Dr MPK Homoeopathic Medical College Hospital and Research Center

Brief Summary

This study is a non-randomized, open-label, single-arm, uni-center interventional trial to assess the effectiveness of Naphthalinum in the management of cases of  Allergic Rhinitis. The primary outcome measures will be according to the scores obtained (pre and post-treatment) from the TNSS scoring method. The secondary outcome will be to verify the symptoms of Naphthalinum in the cases of Allergic Rhinitis.

*Null Hypothesis (H0)* – *Naphthalinum* is not effective in the management of cases of Allergic Rhinitis.

*Alternate Hypothesis (H1)* – *Naphthalinum*is effective in the management of cases of Allergic Rhinitis.

Detailed Description

Not available

Study Timeline

• Study Start: 2022-07-06
• Study Completion: 2023-06-28
• Last Update Posted: 2023-09-21

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

• Diagnostic criteria: Presence of at least two typical symptoms mentioned below: • nasal obstruction • rhinorrhoea (also secretion running down the posterior pharynx) • itching • sneezing occurring for more than an hour a day for more than 2 weeks in a year 2.
• Patients giving consent for the study.
• Patients’ symptoms corresponding to Naphthalinum 4.
• Diagnosed cases of Allergic Rhinitis, taking treatment from other systems of medicine, feeling no relief and seeking homoeopathic treatment.

Exclusion Criteria

• Females, who want to conceive, are pregnant or lactating.
• Patients with any other severe systemic disorder.
• Patients pursuing other treatments are not willing to leave it.
• Allergic Rhinitis complicated with any other serious disease.
• Cases that need surgical intervention.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
According to the scores obtained (pre and post treatment) from the TNSS scoring method	According to the scores obtained (pre and post treatment) from the TNSS scoring method at 3 months

Secondary Outcome Measures

Name	Time	Method
To verify the symptoms of Naphthalinum in cases of Allergic Rhinitis.	1 year

Trial Locations

Locations (1)

Dr. Girendra Pal Homoeopathic Hospital and Research Center; 🇮🇳 Jaipur, RAJASTHAN, India

Dr. Girendra Pal Homoeopathic Hospital and Research Center

🇮🇳Jaipur, RAJASTHAN, India

Dr Aditi Bhinda

Principal investigator

9461402056

aditibhinda94@gmail.com